News | Endoscopes | January 16, 2017

Fujifilm Medical Systems Removes Older Duodenoscopes From Clinical Use

Fujifilm Medical Systems Removes Older Duodenoscopes From Clinical Use

January 16, 2017 — Fujifilm Medical Systems has informed the U.S. Food and Drug Administration (FDA) of its plans to remove its legacy 250/450 duodenoscope models from clinical use. This is based on the limited number currently in use and issues related to reprocessing of these devices leading to reports of multi‐drug resistant bacteria on endoscopes used for endoscopic retrograde cholangiopancreatogram (ERCP) procedures. 

On Jan. 13, 2017, Fuji notified its customers it will replace the 250/450 duodenoscope models with the newer ED-530XT model, in addition to necessary accessories (i.e. brushes) at no cost.

In December 2015, Fuji issued validated manual reprocessing instructions for the ED-530XT duodenoscope to replace those provided in the original device labeling. At that time, the FDA recommended that users and healthcare facilities apply the revised reprocessing instructions for the ED-530XT duodenoscope to reprocess the older 250/450 duodenoscope models while formal validation testing continued for these particular models.

Read letter sent to Fujifilm customers at www.fujifilmusa.com/products/medical/endoscopy/pdf/urgent_field_correction_ed_530XT.pdf

The validated manual reprocessing procedures for the ED-530XT duodenoscope outlined in a December 2015 FDA safety communication remain the same. Healthcare facilities should continue to use these validated instructions when reprocessing Fuji ED-530XT duodenoscope models. The validated reprocessing instructions when followed correctly, are intended to effectively clean and high-level disinfect the Fuji ED-530XT duodenoscope.

The FDA recommendations for healthcare facilities and staff include:
  • Remove from circulation and return your facility’s 250/450 duodenoscope models to Fuji as outlined in Fuji’s Customer Notification Letter.
  • Train appropriate staff on Fuji’s validated reprocessing instructions for the ED-530XT model and implement them as soon as possible.
  • Implement the reprocessing procedures for Fuji’s ED-530XT duodenoscope in accordance with the manufacturer’s reprocessing instructions issued in December 2015.
  • Immediately remove from service to assess, repair and/or replace any duodenoscope that shows signs of damage. Examples of damage may include: loose parts, damaged channel walls, kinks or bends in tubing, holes in the distal end, or other signs of wear or damage.
 • Contact your Fuji sales representative if you have any questions or concerns regarding this removal, a damaged device, or the validated reprocessing instructions for the ED-530XT duodenoscope.

The FDA said it continues to closely monitor the association between reprocessed endoscopes and the transmission of infectious agents by working closely with duodenoscope and automated endoscope reprocessor manufacturers as they validate their reprocessing instructions to a level adequate to clean and high-level disinfect their devices. The FDA also is communicating recommendations to healthcare providers and end users to help mitigate the risk associated with infection transmission and reusable medical devices.

Visit the Infections Associated with Reprocessed Duodenoscopes webpage for a complete listing of actions the agency has taken on this issue. The FDA said it will continue to provide updates as appropriate.

Related Content

Ingenia Ambition X 1.5T MR. This innovation is the latest advance in the Ingenia MRI portfolio, which comprises fully-digital MRI systems, healthcare informatics and a range of maintenance and life cycle services for integrated solutions that empower a faster, smarter, and simpler path to enabling a confident diagnosis
News | Magnetic Resonance Imaging (MRI) | September 14, 2018
Philips, a global leader in health technology, launched the Ingenia Ambition X 1.5T MR.
Videos | Radiation Therapy | September 07, 2018
A discussion with Ehsan Samei, Ph.D., DABR, FAAPM, FSPIE, director of the Duke University Clinical Imaging Physics Gr
Videos | Radiomics | August 09, 2018
A discussion with Martin Vallieres, Ph.D., post-doctoral fellow at McGill University, Montreal, Canada.
Gary D. Luker Named Editor of Radiology: Imaging Cancer

Image courtesy of University of Michigan Medical School

News | Oncology Diagnostics | August 06, 2018
The Board of Directors of the Radiological Society of North America (RSNA) announced that Gary D. Luker, M.D., will...
Videos | Digital Radiography (DR) | August 03, 2018
Sheila Sferrella, president of Regents Health Resources and Bill Finerfrock, president of Capitol Associates, discuss
Videos | AAPM | August 03, 2018
Ehsan Samei, Ph.D., DABR, FAAPM, FSPIE, director of the Duke Un...
New Regulatory Approvals Driving Research and Development Dollars in Medical Imaging Artificial Intelligence
News | Artificial Intelligence | August 01, 2018
Medical imaging has become the bellwether for the application of artificial intelligence (AI) technologies, especially...
Videos | Artificial Intelligence | August 01, 2018
A discussion with Steve Jiang, Ph.D., director of the medical...
Sectra radiation dose monitoring software can help manage radiation dose from multiple medical imaging modalities.
News | Radiation Dose Management | July 25, 2018
July 25, 2018 – Sectra will install its cloud-based,...
Magseed magnetic marker
Technology | Tumor Tracking Systems | July 20, 2018
Endomag, the surgical guidance company, received 510(k) clearance from the U.S.